Clinical Trial Update: Neoadjuvant Concomitant Modulated Electro-hyperthermia in HER2-negative Breast Cancer [Phase 2, Phase 3]

View source ↗

Summary

Neoadjuvant concomitant modulated electro-hyperthermia is being studied for HER2-negative breast cancer in Phase 2/Phase 3 trials; the trial is currently active…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Semmelweis University | Conditions: HER2-negative Breast Cancer | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING